In patients with COVID-19, the close monitoring of D-dimer level to screen for hypercoagulability is recommended; if there is an increasing trend, the introduction of heparin should be considered early in the clinical course.
1
—
—
In patients with COVID-19, the close monitoring of D-dimer level to screen for hypercoagulability is recommended; if there is an increasing trend, the introduction of heparin should be considered early in the clinical course.